Estimation of esophageal involvement length in esophagogastric junction tumors using PET-CT
Open Access
- 28 January 2026
- journal article
- research article
- Published by Springer Nature in Esophagus
- Vol. 23 (2) , 364-371
Abstract
Background: Esophageal involvement length (EIL) is crucial to determining the surgical strategy for esophagogastric junction (EGJ) tumors. This study developed a positron emission tomography–computed tomography (PET-CT)-based method using anatomical landmarks to estimate EIL and evaluated the clinical utility of the model. Methods: We enrolled 50 patients with EGJ adenocarcinoma who underwent surgical resection. Among patients who underwent upfront surgery (Cohort 1, n = 24), craniocaudal distances were measured from the right and left diaphragms and vena cava foramen (VCF) to the proximal tumor margin on PET-CT images and correlated with histological EIL to establish the best-performing model. Predictive ability was validated in patients who underwent surgery after neoadjuvant chemotherapy (Cohort 2, n = 26). Results: In Cohort 1, among the three anatomical landmarks, VCF most strongly correlated with histological EIL ( r = 0.81), providing the following formula: Predicted EIL (mm) = 22 + 0.3 × [Craniocaudal distance from VCF to proximal tumor margin (mm)]. The median absolute difference between the histological and predicted EILs was 4.6 mm (interquartile range, 1.6–6.3 mm), with 96% of cases (23/24) within 10 mm. Evaluation of the model in Cohort 2 found r = 0.81, a median absolute difference of 3.3 mm (interquartile range, 1.1–7.2 mm), and 92% of cases (24/26) within 10 mm. Predictive errors were significantly smaller in both cohorts than in endoscopic findings (Cohort 1, P = 0.004; Cohort 2, P = 0.002). Conclusions: A PET-CT-based approach using the craniocaudal distance from the VCF to the proximal margin could estimate EIL with sufficient accuracy to support surgical decision-making in clinical practice.Keywords
Funding Information
- Osaka University
This publication has 22 references indexed in Scilit:
- Japanese Classification of Esophageal Cancer, 12th Edition: Part IEsophagus, 2024
- Japanese Classification of Esophageal Cancer, 12th Edition: Part IIEsophagus, 2024
- Essential updates 2021/2022: Perioperative and surgical treatments for gastric and esophagogastric junction cancerAnnals of Gastroenterological Surgery, 2023
- Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinomaGastric Cancer, 2016
- PET/CT in Oncology: Current Status and PerspectivesCurrent Radiology Reports, 2013
- Oesophagogastric junction adenocarcinoma: which therapeutic approach?The Lancet Oncology, 2011
- Using 18F-Fluorodeoxyglucose Positron Emission Tomography to Estimate the Length of Gross Tumor in Patients With Squamous Cell Carcinoma of the EsophagusInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmationAnnals of Nuclear Medicine, 2007
- PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trialThe Lancet Oncology, 2007
- A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancerRadiotherapy and Oncology, 2006